ARCHIVES

FDA Approves Velcade Injection In Mantle Cell Lymphoma

This article is from The Cancer Letter archive.

Vol. 37 No. 10 | October 31, 2014

Download PDF Visit The Full Archive

Related Articles

NCAB Gives Life To Three CBCCP Contractors Marked For Termination; Compromise “Reasonable” – DeVita

May 30, 1980

Concepts Approved For Developmental Therapeutics Program

June 19, 1987

NCAB Committee Still Debating How To Encourage Surgical Oncology

April 26, 1985

National Cancer Policy Board will end in 2005, NCI to support a cancer forum at IOM.

November 5, 2004

NCI Advisors To Evaluate SPORE Program; Large Grants to Be Weighed Against R01s

December 12, 1997

NCi Advisors Approve New SPORE Grant Program In Cancer Communications.

December 1, 2000